mevastatin has been researched along with genistein in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Umezawa, K | 1 |
Nguyen, TX; Pento, JT; Siwak, DR; Tari, AM; Zang, XP | 1 |
1 review(s) available for mevastatin and genistein
Article | Year |
---|---|
[Biological activity of oncogene function inhibitors isolated from microorganisms].
Topics: Acyl Coenzyme A; Animals; Bacteria; Furans; Genistein; Hydroquinones; Isoflavones; Lovastatin; Oncogene Proteins; Phosphatidylinositols; Protein-Tyrosine Kinases | 1992 |
4 other study(ies) available for mevastatin and genistein
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2.
Topics: Adaptor Proteins, Signal Transducing; Antifungal Agents; Breast Neoplasms; Cell Movement; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Female; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Genistein; GRB2 Adaptor Protein; Humans; Keratinocytes; Lovastatin; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; RNA, Messenger; Tumor Cells, Cultured | 2004 |